HB 712

Virginia House of Delegates bill in Session 2026.

Status: enacted. Latest action: April 6, 2026.

Office-based buprenorphine treatment; Board of Medicine to amend regulations.

Bill ID VA-2026-HB-712
Session 2026
Status enacted
Committee Health and Human Services; Education and Health
House of Delegates enacted 2026-04-06
Summary

Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care.

Sponsor
Wachsmann
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-13 Introduced Bill introduced
2026-04-06 Status enacted
2026-04-06 Latest Action Acts of Assembly Chapter text (CHAP0207)
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States